The clinical data showed that the expression of METTL3 (Fig. 8C) and ZEB2 (Fig. 8D) in RFs was significantly greater than that in adjacent normal tissues from renal cell carcinoma patients. Here, ZEB2 is linked to hereditary clear cell renal cell carcinoma.